510 related articles for article (PubMed ID: 16715492)
1. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
2. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
[TBL] [Abstract][Full Text] [Related]
3. Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome.
Pedrón VT; Taravini IR; Induni AS; Balerio GN
Synapse; 2013 Mar; 67(3):118-26. PubMed ID: 23152154
[TBL] [Abstract][Full Text] [Related]
4. Morphine withdrawal syndrome: involvement of the dopaminergic system in prepubertal male and female mice.
Diaz SL; Kemmling AK; Rubio MC; Balerio GN
Pharmacol Biochem Behav; 2005 Dec; 82(4):601-7. PubMed ID: 16325246
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice.
Diaz SL; Hermida MP; Joannas LD; Olivera M; Ridolfi A; Villaamil EC; Balerio GN
Biopharm Drug Dispos; 2007 Sep; 28(6):283-9. PubMed ID: 17570125
[TBL] [Abstract][Full Text] [Related]
6. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
7. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
8. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
Pedrón VT; Varani AP; Balerio GN
Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
[TBL] [Abstract][Full Text] [Related]
9. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
10. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice.
Diaz SL; Kemmling AK; Rubio MC; Balerio GN
Behav Pharmacol; 2001 Feb; 12(1):75-9. PubMed ID: 11270515
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
Sánchez-Blázquez P; García-Espãna A; Garzón J
J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
14. Baclofen prevents morphine withdrawal irrespective of seasonal variation.
Kemmling AK; Rubio MC; Balerio GN
Behav Pharmacol; 2002 Feb; 13(1):87-92. PubMed ID: 11990723
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
16. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
17. Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
Diaz SL; Kemmling AK; Balerio GN
Neurochem Int; 2003 Mar; 42(4):293-8. PubMed ID: 12470702
[TBL] [Abstract][Full Text] [Related]
18. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain.
Sharpe LG; Pilotte NS; Shippenberg TS; Goodman CB; London ED
Synapse; 2000 Sep; 37(4):292-7. PubMed ID: 10891866
[TBL] [Abstract][Full Text] [Related]
20. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
Burke TF; Woods JH; Lewis JW; Medzihradsky F
J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
